These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 26833278)
1. DNA damage and antioxidants in treatment naïve children with obsessive-compulsive disorder. Şimşek Ş; Gençoğlan S; Yüksel T Psychiatry Res; 2016 Mar; 237():133-7. PubMed ID: 26833278 [TBL] [Abstract][Full Text] [Related]
2. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Behl A; Swami G; Sircar SS; Bhatia MS; Banerjee BD Neuropsychobiology; 2010; 61(4):210-4. PubMed ID: 20389131 [TBL] [Abstract][Full Text] [Related]
3. Oxidative Stress and DNA Damage in Untreated First-Episode Psychosis in Adolescents. Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Alaca R; Aktaş H Neuropsychobiology; 2016; 73(2):92-7. PubMed ID: 27003298 [TBL] [Abstract][Full Text] [Related]
4. Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. Kandemir H; Abuhandan M; Aksoy N; Savik E; Kaya C J Psychiatr Res; 2013 Nov; 47(11):1831-4. PubMed ID: 24011862 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder. Alici D; Bulbul F; Virit O; Unal A; Altindag A; Alpak G; Alici H; Ermis B; Orkmez M; Taysi S; Savas H Psychiatry Clin Neurosci; 2016 Feb; 70(2):109-15. PubMed ID: 26388322 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D levels in children and adolescents with obsessive compulsive disorder. Yazici KU; Percinel Yazici I; Ustundag B Nord J Psychiatry; 2018 Apr; 72(3):173-178. PubMed ID: 29168423 [TBL] [Abstract][Full Text] [Related]
7. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. Scahill L; Riddle MA; McSwiggin-Hardin M; Ort SI; King RA; Goodman WK; Cicchetti D; Leckman JF J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):844-52. PubMed ID: 9183141 [TBL] [Abstract][Full Text] [Related]
8. 8-F2-isoprostane, thioredoxin and thioredoxin reductase levels in children with obsessive-compulsive disorder. Bilgiç A; Çolak Sivri R; Kılınç İ Nord J Psychiatry; 2018 Oct; 72(7):484-488. PubMed ID: 29927677 [TBL] [Abstract][Full Text] [Related]
17. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting. Yucelen AG; Rodopman-Arman A; Topcuoglu V; Yazgan MY; Fisek G Compr Psychiatry; 2006; 47(1):48-53. PubMed ID: 16324902 [TBL] [Abstract][Full Text] [Related]
18. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Storch EA; Murphy TK; Geffken GR; Soto O; Sajid M; Allen P; Roberti JW; Killiany EM; Goodman WK Psychiatry Res; 2004 Nov; 129(1):91-8. PubMed ID: 15572188 [TBL] [Abstract][Full Text] [Related]
19. The Obsessive-Compulsive Symptom (OCS) scale of the Child Behavior Checklist: a comparison between Swedish children with Obsessive-Compulsive Disorder from a specialized unit, regular outpatients and a school sample. Ivarsson T; Larsson B J Anxiety Disord; 2008 Oct; 22(7):1172-9. PubMed ID: 18280696 [TBL] [Abstract][Full Text] [Related]
20. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder. Ozdemir E; Cetinkaya S; Ersan S; Kucukosman S; Ersan EE Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):62-5. PubMed ID: 18957313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]